Kara, Vijay
Powell, Greg http://orcid.org/0000-0002-1716-5480
Mahaux, Olivia
Jayachandra, Aparna
Nyako, Naashika
Golds, Christopher
Bate, Andrew
Article History
Accepted: 11 June 2023
First Online: 3 August 2023
Change Date: 10 September 2023
Change Type: Update
Change Details: The original article has been corrected. Supplementary material was missing from this article and has now been uploaded.
Declarations
:
: All authors are employed by GSK and declare financial and non-financial relationships and activities. VK, GP, OM, AJ, NN, CG and AB also hold shares/stocks/stock options in the company.
: This work was supported by GlaxoSmithKline Biologicals S.A., which was the funding source. GlaxoSmithKline Biologicals S.A. was involved in all stages of the study conduct and analysis and paid for all costs associated with the development and publishing of this manuscript.
: VK, GP, AJ, NN, CG and AB were involved in the conception or the design of the study. VK, OM, AJ and NN participated in the collection or generation of the study data. VK, GP and OM performed the study. All authors were involved in the analysis or interpretation of the data. All authors reviewed and commented on drafts of the manuscript for intellectual content and gave final approval to submit for publication. All authors attest they meet the ICMJE criteria for authorship.
: The datasets generated and/or analysed during the current study are not publicly available as the study was based on data from the GSK safety database. The data contains PII and confidential/sensitive patient related Information. They could be available from the corresponding author on reasonable request.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.